Guoliang Cui Selected Research

Guoliang Cui Research Topics

Disease

16	Neoplasms (Cancer) 04/2024 - 09/2015
5	Inflammation (Inflammations) 03/2021 - 10/2009
4	Infections 01/2023 - 11/2014
3	Persistent Infection 11/2023 - 11/2014
2	Virus Diseases (Viral Diseases) 11/2023 - 11/2014
2	Ovarian Neoplasms (Ovarian Cancer) 04/2023 - 01/2022
2	COVID-19 01/2023 - 01/2021
2	Microsatellite Instability 01/2022 - 01/2021
2	Stomach Neoplasms (Stomach Cancer) 03/2021 - 01/2021
2	Disease Progression 11/2018 - 05/2009
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2009 - 05/2009
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2024
1	Leukemia 04/2024
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2024
1	Poliomyelitis (Polio) 05/2023
1	Hepatocellular Carcinoma (Hepatoma) 04/2023
1	Carcinogenesis 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Genomic Instability 01/2022
1	Colitis 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Fibrosis (Cirrhosis) 01/2020
1	Coinfection 01/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020
1	Hereditary Sensory and Autonomic Neuropathies (HSAN) 01/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2018
1	Insulin Resistance 09/2017
1	Type 2 Diabetes Mellitus (MODY) 09/2017
1	Reinfection 05/2015
1	Obesity 01/2012
1	Diarrhea 10/2009
1	Multiple Sclerosis 05/2009

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 09/2022 - 11/2018
3	CytokinesIBA 04/2024 - 10/2009
3	Antiviral Agents (Antivirals)IBA 11/2023 - 11/2014
3	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2021
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2015
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	SphingolipidsIBA 04/2024 - 01/2019
2	EnzymesIBA 04/2024 - 11/2023
2	Glutamine (L-Glutamine)FDA Link 11/2023 - 01/2022
2	VaccinesIBA 05/2023 - 01/2021
2	sinovac COVID-19 vaccineIBA 01/2023 - 01/2021
2	InterleukinsIBA 01/2023 - 01/2020
2	LipidsIBA 10/2022 - 01/2021
2	N-methyladenosineIBA 09/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 03/2021
2	GTP-Binding Proteins (G-Protein)IBA 01/2022 - 12/2021
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 11/2014
2	AntigensIBA 01/2019 - 11/2014
2	Peptides (Polypeptides)IBA 09/2017 - 05/2009
1	Mechanistic Target of Rapamycin Complex 1IBA 04/2024
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2024
1	Serine (L-Serine)FDA Link 04/2024
1	safingol (sphinganine)IBA 04/2024
1	AmmoniaIBA 11/2023
1	malic acid (malate)IBA 11/2023
1	NAD (NADH)IBA 11/2023
1	Immune Checkpoint ProteinsIBA 10/2023
1	PPAR gammaIBA 04/2023
1	Amino Acids FDA Link 10/2022
1	6-methyladenineIBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	Inosine FDA Link 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	nitroguanidineIBA 03/2021
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 03/2021
1	Methylnitronitrosoguanidine (MNNG)IBA 03/2021
1	Caspase 3 (Caspase-3)IBA 03/2021
1	Volatile Oils (Essential Oils)IBA 03/2021
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021
1	Polysaccharides (Glycans)IBA 01/2020
1	T Cell Transcription Factor 1IBA 01/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020
1	Serine C-PalmitoyltransferaseIBA 01/2019
1	Viral ProteinsIBA 11/2018
1	ApelinIBA 09/2017
1	PhosphoenolpyruvateIBA 09/2015
1	Interleukin-7 (Interleukin 7)IBA 05/2015
1	Programmed Cell Death 1 ReceptorIBA 11/2014
1	Liver X ReceptorsIBA 01/2012
1	rheinIBA 01/2012
1	Uncoupling Protein 1IBA 01/2012
1	AlkaloidsIBA 10/2009
1	BerberineIBA 10/2009
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2009
1	Glatiramer Acetate (Copaxone)FDA Link 05/2009
1	Interleukin-4 (Interleukin 4)IBA 05/2009

Therapy/Procedure

6	Immunotherapy 10/2023 - 09/2015
5	Therapeutics 10/2023 - 09/2017
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2009
1	Oral Administration 10/2009